A court has heard how a disgraced senior oncologist who indecently assaulted a junior female doctor in 2013, also indecently assaulted the daughter of an elderly prostate cancer patient the year before.
ABC News Australia
According to the American Cancer Society, approximately 1,688,780 new cancer cases will occur in 2017,1 half of which will result in subsequent mortality. Targeted therapeutic cancer approaches, including radiotherapy and protein inhibitors, are common treatment options for improving the likelihood of survival.
Neoadjuvant radiotherapy in patients with early-stage breast cancer significantly lowers the risk of developing secondary primary tumours at any site, new findings suggest.
Specialty Pharmacy Times
Scientists from The University of Manchester have pinpointed a gene signature that identifies which bladder cancer patients would benefit from more aggressive treatment.
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study. Researchers found that irradiation of breast fat produces an inflammatory response that in normal circumstances promotes healing, but in cases of cancer, enables the cancer cells to survive.
Yesterday, Action Radiotherapy highlighted an article on Euratom and the wider implications of Brexit on our health. MarkJohnston.org, a hub for work on European affairs, energy and policy making responded positively on twitter with this article.
This article discusses the current use of volumetric modulated arc therapy (VMAT) techniques in clinical practice and reviews the available data from clinical outcome studies in different clinical settings.
Dove Medical Press
Action Radiotherapy will regularly update our meetings and events page on our website. For up to date meetings and events, please click on the following link.
Euratom is the pan-European regulator that oversees everything nuclear-related in the UK from plutonium stockpiles to imports of radiotherapy treatments for cancer. The impact of leaving this organisation on cancer care is surprisingly unexpected.
Huffington Post UK
NRG-RTOG 0436 has determined that adding an epidermal growth factor receptor (EGFR) inhibitor to a chemo-radiation regimen does not improve overall survival for patients with locally advanced oesophageal cancer treated in a non-operative manner.